Company Search:
Advanced Search
Sponsored Links
Morepen Laboratories Limited Company Snapshot
Morepen Laboratories Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Morepen Laboratories Limited with three other companies in this sector in India: Neuland Laboratories Limited (2016 sales of 5.10 billion Indian Rupees [US$74.76 million] of which 100% was Bulk Drugs), Suven Life Sciences Limited (5.00 billion Indian Rupees [US$73.23 million] of which 94% was Intermediaries under Contract Research/M), and Bliss GVS Pharma Limited (5.47 billion Indian Rupees [US$80.17 million] of which 100% was Pharmaceutical Business).

Sales Analysis. Morepen Laboratories Limited reported sales of 4.85 billion Indian Rupees (US$71.11 million) for the fiscal year ending March of 2016. This represents an increase of 21.1% versus 2015, when the company's sales were 4.01 billion Indian Rupees. Sales at Morepen Laboratories Limited have increased during each of the previous five years (and since 2011, sales have increased a total of 118%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Morepen Laboratories Limited
  Stock Performance Chart for Morepen Laboratories Limited
  Stock Data: Recent Stock Performance:
  Current Price (1/20/2017): 21.60
(Figures in Indian Rupees)
1 Week 3.1%   13 Weeks 4.9%  
4 Weeks -11.7%   52 Weeks -20.1%  
Morepen Laboratories Limited Key Data:
  Ticker: MOREPENLAB Country: India
  Exchanges: BOM Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 4,850,804,000
(Year Ending Jan 2017).
Employees: 1,062
  Currency: Indian Rupees Market Cap: 9,716,245,985
  Fiscal Yr Ends: March Shares Outstanding: 449,826,203
  Share Type: Ordinary Closely Held Shares: 175,737,236
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.